Survival of cancer lung cancers adenocarcinoma. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Lung Cell Line, Tumor Tumor Cells, Cultured Cardia Neoplastic Stem Cells

Organisms3

Mice, Nude Mice, Inbred BALB C Mice, SCID

Diseases41

Adenocarcinoma Lung Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Small Cell Stomach Neoplasms Pancreatic Neoplasms Carcinoma, Squamous Cell Colonic Neoplasms Prostatic Neoplasms Neoplasm Metastasis Esophageal Neoplasms Neoplasm Invasiveness Breast Neoplasms Ovarian Neoplasms Lung Diseases Adenocarcinoma, Mucinous Neoplasms Small Cell Lung Carcinoma Adenocarcinoma, Bronchiolo-Alveolar Disease Progression Carcinoma, Pancreatic Ductal Colorectal Neoplasms Carcinoma Adenocarcinoma, Papillary Neoplasm Recurrence, Local Carcinoma, Large Cell Genetic Predisposition to Disease Endometrial Neoplasms Uterine Cervical Neoplasms Barrett Esophagus Rectal Neoplasms Cell Transformation, Neoplastic Precancerous Conditions Neoplasms, Multiple Primary Lung Injury Urinary Bladder Neoplasms Liver Neoplasms Mammary Neoplasms, Experimental Neovascularization, Pathologic Gastrointestinal Neoplasms Bone Neoplasms

Chemicals and Drugs32

Teniposide Tumor Markers, Biological Antineoplastic Agents Neoplasm Proteins Cisplatin RNA, Messenger Receptor, Epidermal Growth Factor DNA, Neoplasm Cancer Vaccines Tumor Suppressor Protein p53 Quinazolines Deoxycytidine Antigens, Neoplasm RNA, Small Interfering Paclitaxel Antineoplastic Agents, Phytogenic Fluorouracil Receptor, erbB-2 Antibodies, Monoclonal Receptors, Estrogen Protein Kinase Inhibitors Proto-Oncogene Proteins Antimetabolites, Antineoplastic Radon Tumor Suppressor Proteins Taxoids Carcinogens Carcinoembryonic Antigen MicroRNAs Prostate-Specific Antigen RNA, Neoplasm DNA-Binding Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment51

Survival Rate Survival Analysis Early Detection of Cancer Neoplasm Staging Disease-Free Survival Prognosis Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Immunohistochemistry Treatment Outcome Follow-Up Studies Kaplan-Meier Estimate Reverse Transcriptase Polymerase Chain Reaction Risk Factors Combined Modality Therapy Gene Expression Profiling Prospective Studies Neoplasm Transplantation Risk Xenograft Model Antitumor Assays Blotting, Western Multivariate Analysis Risk Assessment Registries Pneumonectomy Chemotherapy, Adjuvant Transplantation, Heterologous Sensitivity and Specificity Odds Ratio Immunoenzyme Techniques Oligonucleotide Array Sequence Analysis Predictive Value of Tests Tumor Burden Tomography, X-Ray Computed Tissue Array Analysis Incidence Polymerase Chain Reaction Cohort Studies Lung Transplantation Drug Administration Schedule SEER Program Drug Screening Assays, Antitumor Case-Control Studies Mammary Neoplasms, Experimental Clinical Trials as Topic Transfection Reproducibility of Results Molecular Targeted Therapy Biopsy Radiotherapy, Adjuvant Radiotherapy

Psychiatry and Psychology1

Phenomena and Processes32

Cell Survival Gene Expression Regulation, Neoplastic Mutation Drug Resistance, Neoplasm Apoptosis Genetic Predisposition to Disease Cell Proliferation Risk Time Factors DNA Methylation Sensitivity and Specificity Signal Transduction Odds Ratio Cell Division Dose-Response Relationship, Drug Genotype Down-Regulation Genes, ras Cell Movement Polymorphism, Genetic Graft Survival Up-Regulation Genes, p53 Promoter Regions, Genetic Gene Expression Genes, Tumor Suppressor Cell Cycle Transfection Base Sequence RNA Interference Cell Growth Processes Gene Silencing

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

Survival National Cancer Institute (U.S.)

Information Science6

Survival Rate Registries Incidence SEER Program Base Sequence Molecular Sequence Data

Named Groups1

Health Care24

Survival Rate Survival Analysis Disease-Free Survival Retrospective Studies Treatment Outcome Follow-Up Studies Kaplan-Meier Estimate Risk Factors Prospective Studies Risk Multivariate Analysis Risk Assessment Registries Age Factors Sensitivity and Specificity Odds Ratio Predictive Value of Tests Incidence Cohort Studies National Cancer Institute (U.S.)SEER Program Case-Control Studies Clinical Trials as Topic Reproducibility of Results

Geographicals2

United States Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Teniposide Adenocarcinoma Lung Neoplasms Carcinoma, Non-Small-Cell Lung Lung Survival Rate Cell Survival Carcinoma, Small Cell Survival Analysis Stomach Neoplasms Pancreatic Neoplasms Early Detection of Cancer Neoplasm Staging Disease-Free Survival Cell Line, Tumor Prognosis Gene Expression Regulation, Neoplastic Tumor Markers, Biological Carcinoma, Squamous Cell Colonic Neoplasms Prostatic Neoplasms Neoplasm Metastasis Esophageal Neoplasms Antineoplastic Agents Neoplasm Invasiveness Retrospective Studies Antineoplastic Combined Chemotherapy Protocols Breast Neoplasms Ovarian Neoplasms Lung Diseases Smoking Mice, Nude Adenocarcinoma, Mucinous Neoplasms Immunohistochemistry Neoplasm Proteins Small Cell Lung Carcinoma Treatment Outcome Adenocarcinoma, Bronchiolo-Alveolar Follow-Up Studies Kaplan-Meier Estimate Disease Progression Reverse Transcriptase Polymerase Chain Reaction Mutation Cisplatin Survival Carcinoma, Pancreatic Ductal RNA, Messenger Risk Factors Combined Modality Therapy Drug Resistance, Neoplasm Gene Expression Profiling Apoptosis Colorectal Neoplasms Tumor Cells, Cultured Prospective Studies Carcinoma Adenocarcinoma, Papillary Neoplasm Recurrence, Local Receptor, Epidermal Growth Factor Carcinoma, Large Cell Genetic Predisposition to Disease DNA, Neoplasm Cell Proliferation Neoplasm Transplantation Risk Xenograft Model Antitumor Assays Blotting, Western Cancer Vaccines Time Factors Endometrial Neoplasms Tumor Suppressor Protein p53 Multivariate Analysis Uterine Cervical Neoplasms Barrett Esophagus Rectal Neoplasms Risk Assessment Registries Pneumonectomy Quinazolines Chemotherapy, Adjuvant Cell Transformation, Neoplastic Age Factors Deoxycytidine Antigens, Neoplasm RNA, Small Interfering Transplantation, Heterologous United States DNA Methylation Sensitivity and Specificity Signal Transduction Odds Ratio Paclitaxel Precancerous Conditions Antineoplastic Agents, Phytogenic Immunoenzyme Techniques Fluorouracil Oligonucleotide Array Sequence Analysis Neoplasms, Multiple Primary Predictive Value of Tests

No FAQ available that match "survival of cancer lung cancers adenocarcinoma"